Sixty-seven people will die today in America because of heroin or narcotic painkillers, if recent overdose statistics are any guide. RAND research offers strategies to save those lives and thousands more around the world.
Legalizing and allowing profit-maximizing firms to produce, sell, and advertise recreational marijuana would likely increase marijuana consumption. But how would this increased consumption influence the use of other substances?
The attitudes of military personnel about drinking predict their future drinking behaviors and may be key to understanding the relationship between normative perceptions about drinking and drinking behaviors.
The study investigates mechanisms thought to support immediate and sustained change after a DMI by analyzing qualitative data collected in community focus groups conducted at three-, six-, and 15-months following a DMI across three different sites.
Following three possible recommendations for medical care for people with an opioid addiction may cut deaths among such patients by as much as one-third. Deaths were much lower among patients who were not prescribed opioids or common types of anxiety medications, those who received psychosocial counseling, and those who had quarterly visits with a physician.
California's Proposition 36 and Arizona's Proposition 200 allowed some drug-abusing criminal offenders to enter drug treatment instead of being incarcerated. This policy brief provides early results of the two programs.
In this June 9th, 2017 congressional briefing, Beau Kilmer, codirector of the RAND Drug Policy Research Center, provides an overview of recent changes in marijuana policies as well as options for the federal government.
Empowering those under criminal justice supervision to cease drug use on their own - rather than forcing them into formal treatment against their will - is a policy approach that warrants further evaluation.
The report sets out the findings of an evaluation that assesses the degree of implementation of the EU Drugs Strategy 2013-2020 and the Action Plan 2013-2016 in all 28 EU Member States in terms of outputs and, where possible, impacts.
This integrated collaborative care protocol was created for a research study that looked at ways to implement medication-assisted and behavioral treatment for patients with opioid and alcohol use disorders in a community health clinic.
Data lags and the elimination of the ADAM program complicate estimates of U.S. cocaine consumption. New users who haven't yet developed cocaine dependence are also a factor. It may be prudent to start planning for an increase in heavy use even before all of the evidence is in.